All posts by: Michael Zand

About Michael Zand

ImmunoCellular Plans Job Cuts in Shift to Stem-to-T-Cell Program – Genetic Engineering & Biotechnology News (press release)

Continue reading

2017-08-24 NEWS

The Herald of Finance

ImmunoCellular Plans Job Cuts in Shift to Stem-to-TCell Program
Genetic Engineering & Biotechnology News (press release)
The company says that Stem-to-TCell offers a more gradual and measured release of killer T cells than chimeric antigen receptor Tcell (CAR-T) technologies, thus avoiding the limited response, and even toxicity, associated with some CAR-T treatments.
ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future StrategyPR Newswire (press release)

all 33 news articles »